Latest Trading Halts News

Breakthrough Minerals Limited has voluntarily suspended trading on the ASX as it prepares to announce a significant mineral project acquisition and capital raising. The suspension is set to last until the announcement or the resumption of trading on 30 October 2025.

OncoSil Medical Limited has addressed ASX concerns over delayed disclosure of PANCOSIL clinical trial results, confirming compliance with continuous disclosure obligations despite procedural oversights.

Pantera Lithium Limited has voluntarily suspended trading of its shares on the ASX pending a significant announcement regarding material tenement agreements, expected by 29 October 2025.

AUB Group Limited has disclosed a conditional, non-binding proposal from an EQT affiliate to acquire the company at $45 per share, following unusual trading activity and media reports.

Scorpion Minerals Limited has requested a voluntary suspension of its ASX-listed securities pending critical announcements on assay results, a tenement application, a strategic partnership, and financing developments.

Australian Oil Company Limited has voluntarily suspended trading on the ASX as it finalizes a capital raising deal, with details expected by 24 October 2025.

Vectus Biosystems has requested an immediate suspension of its ASX-listed shares pending a significant announcement about a transaction involving a compound in its drug library.

PainChek Limited has confirmed FDA De Novo classification for its PainChek Adult App, promptly disclosing the material regulatory milestone to the ASX and signalling a significant step towards US market entry.

Litchfield Minerals has addressed ASX concerns over recent share price spikes, confirming active drilling at its Oonagalabi project and requesting a trading halt pending assay results.

Vectus Biosystems has temporarily paused trading of its securities pending a forthcoming announcement, signaling potential material news for investors.

NSX Limited confirms the legal effectiveness of its acquisition by a Canadian entity, with trading suspended and shareholder payments scheduled.

Johns Lyng Group’s acquisition by Sherwood BidCo has been legally approved, triggering a suspension of JLG shares on the ASX. Shareholders are set to receive $4 per share or scrip consideration by late October.